ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
11.65
-2.06 (-15.03%)
Mar 9, 2026, 4:00 PM EDT - Market closed
ORIC Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 45.67 | 59.41 | 23.38 | 66.84 | 226.01 | Upgrade
|
| Short-Term Investments | 235.82 | 196.55 | 184.8 | 139.43 | 10.97 | Upgrade
|
| Cash & Short-Term Investments | 281.49 | 255.96 | 208.19 | 206.27 | 236.98 | Upgrade
|
| Cash Growth | 9.97% | 22.95% | 0.93% | -12.96% | -19.29% | Upgrade
|
| Prepaid Expenses | 6.98 | 6.29 | 4.41 | 4.18 | 3.54 | Upgrade
|
| Total Current Assets | 288.47 | 262.25 | 212.6 | 210.46 | 240.52 | Upgrade
|
| Property, Plant & Equipment | 9.07 | 11.3 | 12.01 | 14.24 | 14.21 | Upgrade
|
| Long-Term Investments | 110.76 | - | 26.85 | 21.95 | 43.39 | Upgrade
|
| Other Long-Term Assets | 0.59 | 0.59 | 0.55 | 0.53 | 0.52 | Upgrade
|
| Total Assets | 408.89 | 274.14 | 252.01 | 247.18 | 298.64 | Upgrade
|
| Accounts Payable | 3.82 | 1.55 | 0.94 | 1.32 | 1.89 | Upgrade
|
| Accrued Expenses | 13.26 | 20.12 | 16.76 | 11.41 | 11.34 | Upgrade
|
| Current Portion of Leases | 3.33 | 3.18 | 2.75 | 2.66 | 1.93 | Upgrade
|
| Total Current Liabilities | 20.42 | 24.85 | 20.46 | 15.39 | 15.15 | Upgrade
|
| Long-Term Leases | 4.11 | 6.17 | 7.46 | 9.44 | 10.52 | Upgrade
|
| Total Liabilities | 24.53 | 31.02 | 27.92 | 24.83 | 25.67 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,076 | 805.51 | 658.75 | 557.87 | 518.18 | Upgrade
|
| Retained Earnings | -692.24 | -562.77 | -434.93 | -334.23 | -245.11 | Upgrade
|
| Comprehensive Income & Other | 0.79 | 0.38 | 0.26 | -1.29 | -0.1 | Upgrade
|
| Total Common Equity | 384.36 | 243.12 | 224.09 | 222.35 | 272.98 | Upgrade
|
| Shareholders' Equity | 384.36 | 243.12 | 224.09 | 222.35 | 272.98 | Upgrade
|
| Total Liabilities & Equity | 408.89 | 274.14 | 252.01 | 247.18 | 298.64 | Upgrade
|
| Total Debt | 7.44 | 9.36 | 10.21 | 12.1 | 12.44 | Upgrade
|
| Net Cash (Debt) | 274.05 | 246.6 | 197.97 | 194.17 | 224.54 | Upgrade
|
| Net Cash Growth | 11.13% | 24.56% | 1.96% | -13.52% | -23.52% | Upgrade
|
| Net Cash Per Share | 3.12 | 3.54 | 3.85 | 4.90 | 5.92 | Upgrade
|
| Filing Date Shares Outstanding | 100.36 | 71.03 | 67.38 | 45.09 | 39.43 | Upgrade
|
| Total Common Shares Outstanding | 98.53 | 71.02 | 54.87 | 45.09 | 39.43 | Upgrade
|
| Working Capital | 268.05 | 237.4 | 192.14 | 195.07 | 225.37 | Upgrade
|
| Book Value Per Share | 3.90 | 3.42 | 4.08 | 4.93 | 6.92 | Upgrade
|
| Tangible Book Value | 384.36 | 243.12 | 224.09 | 222.35 | 272.98 | Upgrade
|
| Tangible Book Value Per Share | 3.90 | 3.42 | 4.08 | 4.93 | 6.92 | Upgrade
|
| Machinery | 8 | 8.36 | 7.39 | 7.07 | 5.69 | Upgrade
|
| Leasehold Improvements | 2.07 | 2.04 | 1.97 | 1.98 | 1.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.